Artwork

Content provided by Eric Balcavage DC and Dr Eric Balcavage. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Balcavage DC and Dr Eric Balcavage or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Thyroid Shorts Episode 10: Does the Cell Danger Response Apply to Everyone?

38:23
 
Share
 

Manage episode 498419636 series 3668926
Content provided by Eric Balcavage DC and Dr Eric Balcavage. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Balcavage DC and Dr Eric Balcavage or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Dr. Eric Balcavage responds to a thoughtful viewer comment that challenges key aspects of his adaptive thyroid physiology model and Cell Danger Response theory. This deep-dive discussion addresses whether his approach applies to every hypothyroidism case, clarifies the 71% improvement statistic, and explores the role of T3 therapy in thyroid treatment. Key Topics Covered:
  • Does the Cell Danger Response theory apply to all hypothyroidism cases?
  • Clarification of the 71% patient improvement statistic - what it really means
  • Historical use of NDT (Natural Desiccated Thyroid) and treatment evolution
  • Post-Graves disease thyroid management and receptor sensitivity
  • Why T3 therapy works for some patients but doesn't restore physiology
  • The difference between symptom management and true thyroid restoration
  • When to consider alternative approaches for treatment-resistant cases
Dr. Balcavage provides nuanced responses while acknowledging the limitations of current thyroid models, emphasizing that his approach offers hope for patients who haven't found success with conventional T4, NDT, or T3 protocols. Perfect for: Thyroid patients stuck in "thyroid purgatory," healthcare practitioners seeking new perspectives, and anyone interested in understanding why standard thyroid treatments sometimes fail.
  continue reading

100 episodes

Artwork
iconShare
 
Manage episode 498419636 series 3668926
Content provided by Eric Balcavage DC and Dr Eric Balcavage. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eric Balcavage DC and Dr Eric Balcavage or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
In this episode, Dr. Eric Balcavage responds to a thoughtful viewer comment that challenges key aspects of his adaptive thyroid physiology model and Cell Danger Response theory. This deep-dive discussion addresses whether his approach applies to every hypothyroidism case, clarifies the 71% improvement statistic, and explores the role of T3 therapy in thyroid treatment. Key Topics Covered:
  • Does the Cell Danger Response theory apply to all hypothyroidism cases?
  • Clarification of the 71% patient improvement statistic - what it really means
  • Historical use of NDT (Natural Desiccated Thyroid) and treatment evolution
  • Post-Graves disease thyroid management and receptor sensitivity
  • Why T3 therapy works for some patients but doesn't restore physiology
  • The difference between symptom management and true thyroid restoration
  • When to consider alternative approaches for treatment-resistant cases
Dr. Balcavage provides nuanced responses while acknowledging the limitations of current thyroid models, emphasizing that his approach offers hope for patients who haven't found success with conventional T4, NDT, or T3 protocols. Perfect for: Thyroid patients stuck in "thyroid purgatory," healthcare practitioners seeking new perspectives, and anyone interested in understanding why standard thyroid treatments sometimes fail.
  continue reading

100 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play